[1]
M. K. . Karupiah, C. S. . Fong, and N. . Mustafa, “THE EFFECT OF LUSEOGLIFLOZIN ON CARDIOMETABOLIC MARKERS IN PATIENTS WITH PREDIABETES (IMPAIRED GLUCOSE TOLERANCE): A PILOT STUDY”, J ASEAN Fed Endocr Soc, vol. 36, p. 13, Jul. 2021.